Evidence map›Paper›PMID 34820045›Full record

ReviewThe World Allergy Organization journal2021

Harmonizing allergy care-integrated care pathways and multidisciplinary approaches.

Lydia Daniels, Sally Barker, Yoon-Seok Chang, Tinatin Chikovani, Audrey DunnGalvin, Jennifer D Gerdts, Roy Gerth Van Wijk, Trevor Gibbs, Rosalaura V Villarreal-Gonzalez, Rosa I Guzman-Avilan and 15 more

Abstract readReview
In one paragraph

Review in The World Allergy Organization journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Caring for the allergic patient - WAO White Book on Allergy 2026 - 1.The World Allergy Organization journal · 2026
    Review
  3. Adrenaline Auto-Injector Prescribing in Primary Care in England: An Analysis of Non-Standard Dosing.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  4. Identifying and Prioritising BSACI Service Standards for Paediatric Allergy in the United Kingdom.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Seven Steps in Seven Days to Managing Allergy in the Tropics.Research and reports in tropical medicine · 2025
    Article
  9. Minimizing Indoor Allergen Exposure: What Works?Current allergy and asthma reports · 2024
    Review
  10. Review
  11. Article
  12. A novel allergist-integrative model for vaccine allergy safety.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Lydia DanielsFaculty of Medicine, Imperial College London, London, UK.
Sally BarkerFaculty of Medicine, Imperial College London, London, UK.
Yoon-Seok ChangDepartment of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
Tinatin ChikovaniDepartment of Immunology, Tbilisi State Medical University, Tbilisi, Georgia.
Audrey DunnGalvinApplied Psychology and Paediatrics and Child Health, University College Cork, Cork, Ireland.
Jennifer D GerdtsFood Allergy Canada, Toronto, ON, Canada.
Roy Gerth Van WijkSection of Allergology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Trevor GibbsAssociation for Medical Education in Europe (AMEE), Dundee, Scotland, UK.
Rosalaura V Villarreal-GonzalezRegional Center of Allergy and Clinical Immunology, University Hospital "Dr. Jose Eleuterio Gonzalez", Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico.
Rosa I Guzman-AvilanRegional Center of Allergy and Clinical Immunology, University Hospital "Dr. Jose Eleuterio Gonzalez", Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico.
Heather HannaImperial College London, London, UK.
Elham HossnyPediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
Anastasia KolotilinaDepartment of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
José Antonio Ortega MartellHealth Sciences Center, Autonomous University of Hidalgo State, Mexico.
Punchama PacharnDepartment of Pediatrics, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Cindy E de Lira QuezadaRegional Center of Allergy and Clinical Immunology, University Hospital "Dr. Jose Eleuterio Gonzalez", Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico.
Elopy SibandaAsthma, Allergy and Immune Dysfunction Clinic, Twin Palms Medical Centre, Harare, Zimbabwe.
David StukusDivision of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital, Columbus, OH, USA.
Elizabeth Huiwen ThamDepartment of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Carina VenterSection of Allergy and Immunology, University of Colorado Denver School of Medicine, Children's Hospital Colorado, Colorado, USA.
Sandra N Gonzalez-DiazRegional Center of Allergy and Clinical Immunology, University Hospital "Dr. Jose Eleuterio Gonzalez", Faculty of Medicine, Autonomous University of Nuevo León, Monterrey, Mexico.
Michael E LevinDivision of Paediatric Allergy, Department of Paediatrics, University of Cape Town, Cape Town, South Africa.
Bryan MartinDivision of Allergy and Immunology, Department of Otolaryngology, The Ohio State University, Columbus, OH, USA.
Daniel MunblitDepartment of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
John O WarnerInflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a wide time gap between the publication of evidence and the application of new knowledge into routine clinical practice. The consequence is sub-optimal outcomes, particularly concerning for long-term relapsing/remitting conditions such as allergic diseases. In response, there has been a proliferation of published guidelines which systematically review evidence for the gold-standard management of most allergic disorders. However, this has not necessarily been followed by improved outcomes, partly due to a lack of coordination across the patient pathway. This has become known as the "second translational gap". A proposed solution is the development and implementation of integrated care pathways (ICPs) to optimize patient outcomes, with the notion that evidence-based medicine requires evidence-based implementation. ICP implementation is shown to improve short-term outcomes for acute conditions and routine surgery, including reduced length of hospital stay, improved documentation and improved patient safety. However, this improvement is not reflected in patient experience or patient-centered functional outcomes. The implementation of life-long, cost-effective interventions within comprehensive pathways requires a deep appreciation for complexity within allergy care. We promote an evidence-based methodology for the implementation of ICPs for allergic disorders in which all stakeholders in allergy care are positioned equally and encouraged to contribute, particularly patients and their caregivers. This evidence-based process commences with scoping the unmet needs, followed by stakeholder mapping. All stakeholders are invited to meetings to develop a common vision and mission through the generation of action/effect diagrams which helps build concordance across the agencies. Dividing the interventions into achievable steps and reviewing with plan/do/study/act cycles will gradually modify the pathway to achieve the best outcomes. While the management guidelines provide the core knowledge, the key component of implementation involves education, training, and support of all healthcare professionals (HCPs), patients and their caregivers. The pathways should define the level of competence required for each clinical task. It may be useful to leave the setting of care delivery or the specific HCP involved undefined to account for variable patterns of health service delivery as well as local socioeconomic, ethnic, environmental, and political imperatives. In all cases, where competence is exceeded, it is necessary to refer to the next stage in the pathway. The success and sustainability of ICPs would ideally be judged by patient experience, health outcomes, and health economics. We provide examples of successful programs, most notably from Finland, but recommend that further research is required in diverse settings to optimize outcomes worldwide.

Indexed as

AllergyHealthcareIntegrated care pathwaysMultidisciplinary team

Identifiers

PMID34820045
PMCPMC8591185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.